AAAAAA
Results:
1-16
|
Results: 16
Authors:
HAIDAR SH
MORETON JE
LIANG ZM
HOKE JF
MUIR KT
EDDINGTON ND
Citation: Sh. Haidar et al., THE PHARMACOKINETICS AND ELECTROENCEPHALOGRAM RESPONSE OF REMIFENTANIL ALONE AND IN COMBINATION WITH ESMOLOL IN THE RAT, Pharmaceutical research, 14(12), 1997, pp. 1817-1823
Authors:
HOKE JF
CUNNINGHAM F
JAMES MK
MUIR KT
HOFFMAN WE
Citation: Jf. Hoke et al., COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL, ITS PRINCIPLE METABOLITE (GR90291) AND ALFENTANIL IN DOGS, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 226-232
Authors:
HAIDAR SH
MORETON JE
LIANG ZM
HOKE JF
MUIR KT
EDDINGTON ND
Citation: Sh. Haidar et al., EVALUATING A POSSIBLE PHARMACOKINETIC INTERACTION BETWEEN REMIFENTANIL AND ESMOLOL IN THE RAT, Journal of pharmaceutical sciences, 86(11), 1997, pp. 1278-1282
Authors:
HOKE JF
SHLUGMAN D
DERSHWITZ M
MICHALOWSKI P
MALTHOUSEDUFORE S
CONNORS PM
MARTEL D
ROSOW CE
MUIR KT
RUBIN N
GLASS PSA
Citation: Jf. Hoke et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL IN PERSONS WITHRENAL-FAILURE COMPARED WITH HEALTHY-VOLUNTEERS, Anesthesiology, 87(3), 1997, pp. 533-541
Authors:
MINTO CF
SCHNIDER TW
EGAN TD
YOUNGS E
LEMMENS HJM
GAMBUS PL
BILLARD V
HOKE JF
MOORE KHP
HERMANN DJ
MUIR KT
MANDEMA JW
SHAFER SL
Citation: Cf. Minto et al., INFLUENCE OF AGE AND GENDER ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL .1. MODEL DEVELOPMENT, Anesthesiology, 86(1), 1997, pp. 10-23
Authors:
LANG E
KAPILA A
SHLUGMAN D
HOKE JF
SEBEL PS
GLASS PSA
Citation: E. Lang et al., REDUCTION OF ISOFLURANE MINIMAL ALVEOLAR CONCENTRATION BY REMIFENTANIL, Anesthesiology, 85(4), 1996, pp. 721-728
Authors:
DERSHWITZ M
HOKE JF
ROSOW CE
MICHALOWSKI P
CONNORS PM
MUIR KT
DIENSTAG JL
Citation: M. Dershwitz et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL IN VOLUNTEER SUBJECTS WITH SEVERE LIVER-DISEASE, Anesthesiology, 84(4), 1996, pp. 812-820
Authors:
HOKE JF
MUIR KT
GLASS PSA
SHLUGMAN D
ROSOW CE
DERSHWITZ M
MICHALOWSKI P
Citation: Jf. Hoke et al., PHARMACOKINETICS (PK) OF REMIFENTANIL (R) AND ITS METABOLITE (GR90291) IN SUBJECTS WITH RENAL-DISEASE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 148-148
Authors:
CUNNINGHAM FE
HOKE JF
MUIR KT
JAMES MK
HOFFMAN WE
Citation: Fe. Cunningham et al., PHARMACOKINETIC-PHARMACODYNAMIC EVALUATION OF REMIFENTANIL, GR90291, AND ALFENTANIL, Anesthesiology, 83(3A), 1995, pp. 376-376
Authors:
MICHELSEN LG
HOKE JF
HUG CC
BEIQUE FA
BRANDON B
KIRKHART BA
Citation: Lg. Michelsen et al., PHARMACOKINETICS OF REMIFENTANIL IN CARDIAC SURGICAL PATIENTS, Anesthesiology, 83(3A), 1995, pp. 379-379
Authors:
SEBEL PS
HOKE JF
WESTMORELAND C
HUG CC
MUIR KT
SZLAM F
Citation: Ps. Sebel et al., HISTAMINE CONCENTRATIONS AND HEMODYNAMIC-RESPONSES AFTER REMIFENTAMIL, Anesthesia and analgesia, 80(5), 1995, pp. 990-993
Authors:
HOKE JF
YUH L
ANTONY KK
OKERHOLM RA
ELBERFELD JM
SUSSMAN NM
Citation: Jf. Hoke et al., PHARMACOKINETICS OF VIGABATRIN FOLLOWING SINGLE AND MULTIPLE ORAL DOSES IN NORMAL VOLUNTEERS, Journal of clinical pharmacology, 33(5), 1993, pp. 458-462
Authors:
DURHAM SL
HOKE JF
CHEN TM
Citation: Sl. Durham et al., PHARMACOKINETICS AND METABOLISM OF VIGABATRIN FOLLOWING A SINGLE ORALDOSE OF [C-14] VIGABATRIN IN HEALTHY MALE-VOLUNTEERS, Drug metabolism and disposition, 21(3), 1993, pp. 480-484
Authors:
WESTMORELAND CL
HOKE JF
SEBEL PS
HUG CC
MUIR KT
Citation: Cl. Westmoreland et al., PHARMACOKINETICS OF REMIFENTANIL (GI87084B) AND ITS MAJOR METABOLITE (GI90291) IN PATIENTS UNDERGOING ELECTIVE INPATIENT SURGERY, Anesthesiology, 79(5), 1993, pp. 893-903
Authors:
WESTMORELAND C
SEBEL PS
HUG CC
HOKE JF
MUIR KT
Citation: C. Westmoreland et al., HISTAMINE LEVELS AND HEMODYNAMIC-RESPONSES FOLLOWING REMIFENTANIL, Anesthesiology, 79(3A), 1993, pp. 10000111-10000111
Authors:
WESTMORELAND C
HOKE JF
SEBEL PS
HUG CC
MUIR KT
Citation: C. Westmoreland et al., PHARMACOKINETICS OF REMIFENTANIL (GI87084B) AND ITS METABOLITE, Anesthesiology, 79(3A), 1993, pp. 10000372-10000372
Risultati:
1-16
|